Cancer Treatment-Induced Dry Mouth is ‘Much More Consequential Than It Sounds’

Video

Cancer-treatment induced dry mouth can lead to several severe health issues. Here, Dr. Randy Kimple discusses how the side effect can lead to dental health issues, as well as other health consequences including pneumonia.

Saliva, or lack thereof, greatly impacts a person’s dental health. In fact, according to Dr. Randy Kimple, patients who experience lifelong dry mouth after receiving treatment for cancer tend to end up having bad dental health issues and can also aspirate and develop pneumonia and other complications.

In an interview with CURE® explaining how an experimental therapy may benefit patients with cancer experiencing treatment-related dry mouth, Kimple, an associate professor in the Department of Human Oncology and radiation oncologist at the University of Wisconsin Carbone Cancer Center, highlighted how severe the consequences of this side effect could be.

For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Transcript:

The effects on the saliva impact the dental health in ways you know, it's not just (to) brush your teeth more, but the saliva that your teeth are always surrounded by helps protect the teeth and maintain them. So, these people end up with bad dental issues, they can aspirate, which essentially means that when they try to swallow, whether it's their saliva or food, it goes down the wrong pipe.

We all do that once in a while, right? You cough, it's fine. But these people do it chronically. And that can lead to infections, pneumonia and other complications. These patients, some of them, you know, won't eat food outside of their home. When we could go to restaurants (outside of COVID-19), they won't go to a restaurant to have dinner, because it's embarrassing that they can't eat the food or that they take a bite of chicken and they have to chew the chicken for five minutes and take three sips of water to eat one small bite of chicken. And, you know, they say, ‘I can't do it.’ It affects their social functioning and even who they spend time with.

So, it it's much more consequential than it sounds initially, and if you talk to patients who had radiation, I think you'll be impressed by how impactful it really is. Even though on the surface it sounds like dry mouth is not a big deal. That's not at all the story that our patients tell us.

Related Videos
Jessica McDade, B.S.N., RN, OCN, in an interview with CURE
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Image of a woman with brown shoulder-length hair in front of a gray background that says CURE.
Dr. Andrea Apolo in an interview with CURE
Dr. Kim in an interview with CURE
Related Content